Stock listing

Marker Therapeutics, Inc.

Selected listing: MRKR · BOATS · USD · US

Marker Therapeutics, Inc. (BOATS:MRKR), Health Technology. Latest release Mar 18, 2026: Marker Therapeutics Reports Year-End 2025 Corporate and Financial…

MRKR:BOATSUSDUSUpdated October 2, 2026
Marker Therapeutics, Inc. logo
Ticker
BOATS:MRKR
Asset type
Stock
Sector
Health Technology
Industry
Biotechnology
Exchange
BOATS
Currency
USD

About Marker Therapeutics, Inc.

Marker Therapeutics, Inc. (MRKR) is a public company based in the United States, focused on developing innovative cell therapies for cancer treatment. Marker Therapeutics aims to address unmet medical needs in oncology through its unique approach to immunotherapy.

Latest news from Marker Therapeutics, Inc.

All Marker Therapeutics, Inc. news →

Events

Replays

  • Marker Therapeutics, Inc. (MRKR) Q2 2022 Earnings Call

    Wed, Feb 16, 2022 · 05:00 PM ET

    Watch

Research Marker Therapeutics, Inc.

Alternate listings